Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 5,682 shares at $506.68 ($2.9M) on 2026-05-22, disclosed to the SEC on 2026-05-22.
Scheduled sale ($2.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $506.68 | 40 | $20K | 0.7% |
| 2 | $508.24 | 320 | $163K | 5.6% |
| 3 | $510.36 | 151 | $77K | 2.6% |
| 4 | $511.40 | 610 | $312K | 10.7% |
| 5 | $512.50 | 439 | $225K | 7.7% |
| 6 | $512.97 | 40 |
| $21K |
| 0.7% |
| 7 | $514.67 | 343 | $177K | 6.0% |
| 8 | $515.92 | 657 | $339K | 11.6% |
| 9 | $516.87 | 723 | $374K | 12.8% |
| 10 | $517.59 | 1,497 | $775K | 26.5% |
| 11 | $518.76 | 782 | $406K | 13.9% |
| 12 | $519.98 | 80 | $42K | 1.4% |
| Total | $515.44 avg | 5,682 | $2.9M | 100% |
| Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $4.1M | — | Filing → |